A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use
David Price, Yumi Asukai, Jaithri Ananthapavan, Bill Malcolm, Amr Radwan, Ian Keyzor
Dive into the research topics of 'A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use'. Together they form a unique fingerprint.